Sunesis Pharmaceuticals Inc. Files SEC Form 4 on August 26, 2015

Sunesis Pharmaceuticals Inc., a U.S. pharmaceutical company, filed a SEC Form 4 on August 26, 2015, revealing details about the company's financial activities and executive movement. The filing, made publicly available through the SEC's EDGAR database, provides insight into the company's SIC code 2834, Pharmaceutical Preparations, and its operations in the industry. The document, filed by the company under Form 4, is a mandatory disclosure for directors, officers, and owners of over 10% of equity securities registered under Section 12 of the '34 Act.

Key Takeaways:

Sunesis Pharmaceuticals Inc. filed a SEC Form 4 with the SEC on August 26, 2015, disclosing information on the company's financial activities and executive movement.
The filing, made under Form 4, is required for directors, officers, and owners of over 10% of equity securities registered under Section 12 of the '34 Act.
The SIC code for Sunesis Pharmaceuticals Inc. is 2834, indicating its involvement in the pharmaceutical preparations industry.
The company's contact information, as listed in the form, includes its address at 395 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO CA 94080, and its phone number, 650-266-3500.
The SEC filing is a formal document submitted to the SEC by publicly-traded companies, providing transparency into their financial activities and business operations.

Statistics:

Date of SEC filing: August 26, 2015
SIC code: 2834 (Pharmaceutical Preparations)
Number of documents filed: 1
SEC file number: 0001179110-15-012683
Contact information: 395 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO CA 94080, 650-266-3500

Sources:

"Sunesis Pharmaceuticals Inc. (Form 4) (0001179110-15-012683)" - SEC EDGAR database (August 26, 2015)
U.S. Securities and Exchange Commission (SEC) - http://www.sec.gov